ANNA MALOVANNAYA to Myeloproliferative Disorders
This is a "connection" page, showing publications ANNA MALOVANNAYA has written about Myeloproliferative Disorders.
Connection Strength
0.420
-
Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase. Blood Adv. 2025 Nov 11; 9(21):5598-5609.
Score: 0.215
-
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML. Blood. 2025 02 06; 145(6):612-624.
Score: 0.204